The pharmaceutical industry swears the high cost of drugs is due to research and development costs, conveniently omitting the actual amount of money spent on the marketing of these drugs, which is exorbitantly more. A recent Deloitte report suggests that pharmaceutical companies are taking a hit because investments made in R&D on new drugs simply are not paying off anymore. [1] Read …
Turning Point – 11.16.15
Uncovering the systemic child-abuse in the Catholic Church. An interview with David Clohessy, Executive Director of SNAP (Survivors Network of those Abused by Priests.)